Novel drugs against tuberculosis: a clinician's perspective.
about
Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Delivery of RNAi Therapeutics to the Airways-From Bench to BedsideTradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based AnalysisIn silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatmentEffects of Lipid-Lowering Drugs on Vancomycin Susceptibility of MycobacteriaNanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosisDrug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.Synthetic investigational new drugs for the treatment of tuberculosis.Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.Biotransformation and bioactivation reactions - 2015 literature highlights.The changing landscape in drug resistant-tuberculosis: an analysis of recent advances.Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms.Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring.Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner.Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children.Challenges and recent progress in drug discovery for tropical diseases
P2860
Q26771997-F5886176-41B2-4335-9D24-B33832A4D0C5Q28067306-B9CBE6F3-C13F-4800-9471-43A94951FE1DQ28554607-952A584B-114F-4869-A3AA-5F77AA792582Q35960910-1F94F306-6E33-4CF6-A807-57D57370E29AQ37287716-4F161602-9D6F-4DB3-A17B-161D045A75B8Q37722890-3E0422A5-76EB-49A7-B22A-E29030C7C703Q38604890-D3FF0006-8BDE-4A73-9319-9E731260F04BQ38635790-B1FE880A-3EF0-4284-9DB5-B7E492553254Q38872058-861967D8-6208-4692-B26E-1F5E86DFFF60Q38881705-A4365169-0F36-41D1-86DF-3A22F8056F1BQ39262652-5A38C3C8-9C1F-4300-A630-B91AC99DCB5CQ40428516-3D1BB007-BF9E-4C80-B677-E2D6A0E762F8Q40474018-FB127670-A347-4CAC-B437-B47C0A3CD89CQ40474339-BC58CF42-3A9D-4250-B828-7B3110B7ED08Q40879670-CFAFFDBB-9D7D-4752-8B83-1A9E3ACFC4C7Q47244908-33FAE3CB-A73E-4F7F-97F0-23FA07EB6C23Q59073293-40F742E8-DA28-4871-B105-38CB57AE3250
P2860
Novel drugs against tuberculosis: a clinician's perspective.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Novel drugs against tuberculosis: a clinician's perspective.
@en
type
label
Novel drugs against tuberculosis: a clinician's perspective.
@en
prefLabel
Novel drugs against tuberculosis: a clinician's perspective.
@en
P2093
P1476
Novel drugs against tuberculosis: a clinician's perspective
@en
P2093
Florian von Groote-Bidlingmaier
Jan Heyckendorf
Kwok Chiu Chang
Wing Wai Yew
P304
P356
10.1183/09031936.00162314
P577
2014-11-27T00:00:00Z